B.Sc. (Chemistry Honors), MBA (Investment, ICFAI)
B.Sc., MBA, Partner, 15+ years of experience, a finance professional and chemistry background has an in depth understanding of the complex steps of drug development along with risks and rewards associated for a given drug. His acquired understanding of drugs and diseases helped him author/ Co-author detailed therapy class/specific diseases reports. Sanjeev’s multitasking ability and experience provides valuable financial and technical input required in evaluating biotech/pharma companies.
Earlier at MP Advisors, he worked on various projects related to Feasibility Studies, Merger and acquisition, Joint Venture, Business Evaluation, Identifying NCE Licensing Opportunities, and Business & Technological Due Diligence of Products, Pharma and Nutraceutical Companies. He was following various large cap Biopharma and Biotech companies, mainly from US, EU, Japan and India.
He worked with renowned Private Equity Investors in India, and is also an author of many therapeutic class reports. Prior to joining MP Advisors, he worked with Guggenheim-Transparent Value LLC, an asset management company as a Senior Financial Analyst. As an integral part of study, he worked on a project, “Market Opportunity of Anti-Cancer drugs in India” at Shantha Biotech (A Sanofi company).